A Novel Approach to ALS Trial Development
On-Demand Webinar Archive
To access the archived recording of this webinar, visit our webinar channel and complete a one time only form. This will give you access to our entire library of archived webinars.
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder affecting some 40,000 individuals in Europe at any time, causing 10,000 deaths each year. As with other age-related neurodegenerative diseases, the drug development field is littered with inconclusive or negative trials.
Modifying Immune Response and Outcomes in ALS (MIROCALS) is an international European Union H2020-funded trial of low-dose interleukin-2 in motor neurone disease (MND)/ALS. It aims to break this impasse in the development of disease-modifying agents through novel trial design, incident (early post-diagnosis) recruitment, integration of biomarkers/transcriptomics and cohort stratification.
Join this webinar to hear about an overview of the study in addition to a discussion of the challenges – both anticipated and unanticipated – in recruiting participants recently diagnosed with a rare, rapidly disabling and ultimately life-limiting condition.
Speakers
P. Nigel Leigh, BSc, MB BS, PhD, FRCP, FAAN, FMedSci -
Coleader of MIROCALS, P. Nigel Leigh is Emeritus Professor at King’s College London, Honorary Consultant Neurologist at Brighton and Sussex University Hospitals Trust and Director of the Sussex MND Care and Research Network. He is also Professor of Neurology at Brighton and Sussex Medical School, since his appointment in 2011. His research continues to focus on the causes, mechanisms, and treatment of MND and related neurodegenerative disorders.
Brian Dickie, PhD
Brian Dickie has an academic research background in pharmacology and neuroscience. As Director of Research for the MND Association of England, Wales and Northern Ireland, he oversees a portfolio of over 90 research projects, spanning basic, clinical and healthcare research. Additional roles include raising the Association’s profile within the biomedical research community, facilitating collaborative research and communicating advances in MND research to lay and specialist audiences.